ArticleProceedings of the National Academy of Sciences of the United States of America2010

Design of a potent CD1d-binding NKT cell ligand as a vaccine adjuvant.

Xiangming Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.